Home » RainDance Closes $16.5M Series E Financing Round Extension

RainDance Closes $16.5M Series E Financing Round Extension

Mar 03, 2014
|
staff reporter

NEW YORK (GenomeWeb News) – RainDance Technologies today said that it has closed a $16.5 million Series E financing round extension.

New investors GE Healthcare and Northgate Capital participated in the round as did existing investors. The financing, Billerica, Mass.-based RainDance said, will be used to accelerate its commercial expansion and assay development work.

RainDance also is developing a liquid biopsy method that uses "readily accessible fluids" and is minimally invasive and inexpensive, it added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

What's Popular?

In PCR

  1. Nanopore Sequencing, PCR Platforms Evaluated for Rapid Pneumonia Diagnosis in UK Study

    Premium

  2. Roche Includes Cobas HIV-1/HIV-2 Test in Global Access Program

  3. Luminex Receives FDA Clearance for C. Diff Assay

  4. Rice U Team Debuts Modular Probe Method to Detect Hypervariable, Long, or Repetitive DNA Sequences

    Premium

  5. Startup SpinDiag Raises €1.6M in Seed Funding

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.